Nonalcoholic steatohepatitis or NASH is a common, often "silent" liver disease which affects about 2%-5% of Americans4-6. NASH is strongly associated with the metabolic syndrome, diabetes type-2 and obesity and can lead to cirrhosis, HCC, liver transplantation or death. The only mean for proving a diagnosis of NASH and separating it from simple fatty liver is liver biopsy (an invasive procedure which carries a certain degree of risk). Currently, there is no effective treatment for NASH7.